Patient and aneurysm characteristics
| Variable | n=66 |
| Age (years) | 69 (57–75) |
| Women | 57 (86) |
| Comorbidities | |
| Hypertension | 37 (56) |
| Dyslipidemia | 25 (38) |
| Diabetes mellitus | 4 (6) |
| History of smoking | 21 (32) |
| Aneurysm characteristics | |
| Aneurysm size (mm) | 18.7 (16.0–23.0) |
| Aneurysm neck (mm) | 8.1 (6.1–10.7) |
| Aneurysm location | |
| Cavernous portion | 50 (76) |
| Paraclinoid portion | 15 (23) |
| ICA-PC | 1 (2) |
| Cranial neuropathy (n=89) | |
| CN II | 22 (25) |
| CN III | 27 (30) |
| CN IV | 1 (1) |
| CN V | 11 (12) |
| CN VI | 28 (31) |
| Multiple cranial neuropathy | 16 (24) |
| Symptom onset-to-treatment (months.) | 4 (2–9) |
| Procedure characteristics | |
| Multiple stents used | 10 (15) |
| Adjunctive coiling | 18 (27) |
| VER (%) | 14.1 (10.7–17.5) |
| Clinical follow-up (months.) | 39 (26–55) |
| Steroid use | 19 (29) |
| Aneurysm occlusion at 6 months | |
| OKM grade: D | 27 (41) |
| OKM grade: C-D | 49 (74) |
| Aneurysm occlusion at 12 months. | |
| OKM grade: D | 46 (70) |
| OKM grade: C-D | 56 (85) |
| Morbidity | |
| Symptomatic hemorrhagic stroke | 1 (2) |
| Symptomatic ischemic stroke | 1 (2) |
| 30-Day major stroke | 0 (0) |
| Re-treatment | 8 (12) |
Values shown are medians (IQR) or numbers (%).
CN, cranial nerve; ICA-PC, internal carotid artery–posterior communicating artery; OKM, O’Kelly–Marotta; VER, volume embolization rate.